Captrust Financial Advisors Amphastar Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $148,863 - $210,563	3,346 New	3,346 $206,000
Q2 2022 Aug 16, 2022	BUY	$29.79 - $42.29 $6,553 - $9,303	220 Added 7.94%	2,990 $104,000
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $33,934 - $53,873	1,478 Added 114.4%	2,770 $99,000
Q4 2021 Feb 14, 2022	BUY	$18.14 - $23.29 $1,995 - $2,561	110 Added 9.31%	1,292 $30,000
Q3 2021 Nov 16, 2021	SELL	$17.83 - $21.49 $2,228 - $2,686	-125 Reduced 9.56%	1,182 $22,000
Q2 2021 Aug 16, 2021	SELL	$17.11 - $20.92 $3,165 - $3,870	-185 Reduced 12.4%	1,307 $26,000
Q1 2021 May 17, 2021	BUY	$17.21 - $20.65 $24,386 - $29,261	1,417 Added 1889.33%	1,492 $27,000
Q4 2020 Feb 16, 2021	BUY	$17.76 - $21.24 $1,332 - $1,592	75 New	75 $2,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.